Regular coffee intake halves death risk for patients with HIV, hepatitis C
Researchers say that a higher coffee intake could lower the risk of all-cause death for patients with Human Immuno-deficiency Virus (HIV)-Hepatitis C Virus (HCV) co-infection.
Molecule kills HIV as single-day pill offers one-year treatment
Scientists have designed a synthetic molecule that can reactivate dormant human immunodeficiency virus (HIV) in mice and lead to the death of some of the infected cells, according to a study published in PLOS Pathogens.
Africa to get state-of-art HIV drugs for $75 per patient a year
The drug was originally developed by ViiV Healthcare, the HIV business majority-owned by GlaxoSmithKline (GSK.L). ViiV has offered licensing deals to generic companies to sell low-cost versions of the medicine in poor countries.
Nigerians’ life expectancy shortened by malaria, others
Nigerians are living 7.55 years longer at average life expectancy of 65 years but are still battling with communicable diseases such as Human Immuno-deficiency Virus (HIV), malaria, diarrhoea and neonatal ailments like sepsis and encephalopathy.
World lags badly on targets to slash TB, HIV, obesity - study
Not a single country, out of nearly 200 reviewed, was on track to meet the UN target of eliminating new tuberculosis infections by 2030, according to a global health review published Wednesday.
Pneumonia, bronchitis overtake HIV/AIDS as leading cause of death in Africa, WHO study reveals
Pneumonia and bronchitis have overtaken Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) as the leading cause of death for people in Africa.
HIV injection taken every two months scraps need for daily drugs
Currently HIV patients have to take antiretroviral medication each day to stop it from weakening their immune system and leading to Acquired Immune Deficiency Syndrome (AIDS).
First generic Hepatitis C medicine, HIV self-test prequalified by WHO
“Having quality-assured self-tests is essential to enable countries to implement more rapidly. It is a positive step towards making innovative HIV self-testing accessible to all those who would benefit from it.”